HDB Financial Services, the non-banking financing arm of HDFC Bank, is gearing up for its largest-ever IPO—₹12,500 crore—set to open on June 25 and close on June 27, 2025. In the days leading up to the launch, enthusiasm in the grey market has been brisk, with the Grey Market Premium (GMP) hovering around 6.3% (₹47–48 per share) above its upper IPO band of ₹740. This robust GMP underpins strong investor sentiment and bodes well for a healthy listing trajectory.
What Is GMP Telling Investors?
Grey Market Premium (GMP) serves as an unregulated indicator of market demand before IPOs. At 6.35%, the current GMP suggests expected listing price near ₹787 per share—a solid double-digit debut. However, some sources report even higher GMP levels of 10–12% (₹83–₹89), implying a potential listing price of ₹823–₹829.
It’s important to note that GMPs reflect speculative sentiment in informal markets and may not fully align with official listing prices. Earlier exuberance saw HDB Financial unlisted at ₹1,200–1,350—70–80% above the issue price—dominated by FOMO, but cooled once fundamentals became clearer.
IPO Valuation & Offering Structure
- Price Band: ₹700–₹740 per share
- Offer Size: ₹12,500 crore
- Fresh issue: ₹2,500 crore (approximately 3.38 crore shares)
- Offer for Sale (OFS): ₹10,000 crore (around 13.5 crore shares by HDFC Bank)
- Share Allocation: 50% QIBs, 35% Retail, 15% NIIs, with ₹1,250 crore (≈1.69 crore shares) earmarked for HDFC Bank shareholders
- Lot Size: Minimum 20 shares per retail application (₹14,000–₹14,800)
Analysts value HDB’s IPO at a Price-to-Book ratio of 3.72× (at ₹740), in line with peers Bajaj Finance and Shriram Finance. Despite grey market valuations peaking earlier (≈70–80%), the formal listing price aligns with fundamental valuation ranges of 3.2–3.4× PBV.
Risk Considerations: What Investors Must Know
The IPO’s draft prospectus lists ten critical risks—among the key ones:
- Promoter Shareholding: RBI may mandate HDFC Bank to pare its stake below 20% due to regulatory conflicts, potentially affecting governance or strategic control.
- Asset Quality: Gross Stage-3 (NPA) loans rose from 1.90% to 2.26% YoY; unsecured loan exposure (~27%) could impact credit risk.
- Over-Reliance on Borrowing & Funding Costs: As a large NBFC, fluctuations in wholesale rates could impact profitability.
- Potential Conflicts: Intra-group transactions with HDFC Bank might raise competition/regulatory concerns.
- Industry Competition: Fierce rivalry among NBFCs and fintechs adds pressure on margins.
- Economic Cycles: Any downturn may lead to higher slippages and subdued loan demand.
Should You Subscribe? Points to Ponder
Strong Parentage & Franchise
- 94% of HDB Financial is owned by HDFC Bank, one of India’s most trusted lenders.
- Boasts a diversified business across personal, enterprise, and asset financing with ~1,747 branches nationwide.
Solid Growth & Capital Position
- FY23–24 saw ~21% growth in loan book and a 56% jump in Net Profit.
- Fresh issue proceeds are earmarked to bolster Tier‑I capital and support growth plans.
Conservative Pricing
- Valuations align reasonably with listed NBFCs amid broader market slowdown.
- GMP around 6–11% suggests moderate listing upside expectations.
Exercise Caution
- Bake in risks: asset quality, regulatory shifts, and macro downturns.
- Avoid speculative decisions based purely on high GMP.
IPO Snapshot – At a Glance
| Segment | Details |
|---|---|
| Price Band | ₹700–₹740 |
| Issue Size | ₹12,500 crore (Fresh: ₹2,500; OFS: ₹10,000 cr) |
| Lot Size | 20 shares (Retail) |
| GMP | ₹47–48/share (~6.3%), ranges ₹83–₹89 (~11%) |
| Valuation | ~3.7× FY24 PBV (@₹740); ~3.2–3.4× per peers |
| Anchor Bookbuilders | 12 banks including Goldman, BofA, Jefferies |
| Listing Date | Tentatively July 2, 2025 |
Key Takeaway
HDB Financial’s IPO appears well-priced, reflecting credible fundamentals, strong brand backing, and reasonable grey market premiums in the 6–11% range. If considering participation:
- Subscribe moderately if you seek a stable return tied to NBFC valuation comfort.
- Weigh upside against inherent risks and avoid over-reliance on speculative GMP gains.
- Ideal for investors seeking long-term franchise value rather than short-term listing arbitrage.
Also Read: Rupee Drops 17 Paise to 86.72 Amid Rising Crude Oil & Geopolitical Tensions
